Unilateral intraputaminal glial cell line-derived neurotrophic factor in patients with Parkinson disease: response to 1 year each of treatment and withdrawal.

Neurosurgical focus

Volumn 20, Issue 5, 2006, Pages

  Slevin, John T ^a   Gash, Don M ^a   Smith, Charles D ^a   Gerhardt, Greg A ^a   Kryscio, Richard ^a   Chebrolu, Himachandra ^a   Walton, Ashley ^a   Wagner, Renee ^a   Young, A Byron ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARKINSON AGENT; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; LEVODOPA;

AGED; ARTICLE; DRUG ADMINISTRATION; DRUG EFFECT; FEMALE; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; MOVEMENT (PHYSIOLOGY); PARKINSON DISEASE; PATHOPHYSIOLOGY; PHASE 1 CLINICAL TRIAL; PUTAMEN; TREATMENT OUTCOME;

AGED; ANTIPARKINSON AGENTS; CLINICAL TRIALS, PHASE I; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HUMANS; LEVODOPA; MALE; MIDDLE AGED; MOVEMENT; PARKINSON DISEASE; PUTAMEN; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 33745093230     PISSN: None     EISSN: 10920684     Source Type: Journal    
DOI: 10.3171/foc.2006.20.5.2     Document Type: Article

References (0)